News & Updates

Combining toripalimab with gemcitabine and cisplatin chemotherapy is safe and efficacious in patients with muscle-invasive bladder cancer (MIBC), demonstrating its potential as a neoadjuvant treatment (NAT) in a phase II clinical trial.

A recent study has found a paradoxical change in the microbiome structure in the development of severe gastric mucosal atrophy, which appears to have a significant association with the progression of gastric atrophy and gastric cancer risk.

Treatment with nivolumab plus relatlimab results in a lower incidence of severe immune-related adverse events (irAEs), delayed onset of irAEs, and reduced rate of treatment discontinuation among patients with advanced cutaneous melanoma when compared with ipilimumab plus nivolumab, reports a study.

Pharmacists working in hospitals do not see themselves competent enough to handle cancer patients, a study has shown.

Consumption of sugar-sweetened beverages may contribute to an increased risk of liver cancer, according to a meta-analysis.